Acadia Pharmaceuticals's three largest insider shareholders as of May 30, 2026 are Bros. Advisors Lp Baker (Director, 39.37Mn shares), Stephen Davis (Ceo, 186.56K shares), Mark C. Schneyer (Evp, Chief Financial Officer, 62.84K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Stephen Davis | Ceo | 186,555 | 0 | 20 Aug, 2024 |
| Bros. Advisors Lp Baker | - | 0 | 39,365,965 | 02 Jun, 2025 |
| Daniel B Soland | - | 44,041 | 0 | 02 Jun, 2025 |
| Laura Brege | - | 15,095 | 0 | 05 Jun, 2025 |
| Srdjan R. Stankovic | President | 61,234 | 0 | 22 Nov, 2022 |
| Jennifer J Rhodes | Evp, Chief Legal Officer, Sec | 11,280 | 0 | 26 Mar, 2026 |
| Austin D. Kim | Evp,General Counsel, Secretary | 46,901 | 0 | 09 Jan, 2024 |
| James Kihara | Principal Accounting Officer | 27,865 | 0 | 07 Apr, 2026 |
| Adams Catherine Owen | Chief Executive Officer | 14,803 | 0 | 26 Mar, 2026 |
| Elizabeth H.Z. Thompson | Evp, Head Of Research Dev | 3,280 | 0 | 26 Mar, 2026 |
| Adora Ndu | - | 24,801 | 0 | 02 Jun, 2025 |
| Brendan Teehan | Evp, Coo, Head Of Commercial | 62,105 | 0 | 19 Nov, 2024 |
| Mark C. Schneyer | Evp, Chief Financial Officer | 62,836 | 0 | 07 Apr, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 05 Apr, 2026 | James Kihara | Common Stock | A | 2,010 | - | 28,895 | D | M |
| 05 Apr, 2026 | James Kihara | Common Stock | A | 2,010 | - | 28,895 | D | M |
| 05 Apr, 2026 | Mark C. Schneyer | Common Stock | A | 5,276 | - | 65,545 | D | M |
| 07 Apr, 2026 | James Kihara | Common Stock | D | 1,030 | $22.20 | 27,865 | D | S |
| 07 Apr, 2026 | Mark C. Schneyer | Common Stock | D | 2,709 | $22.20 | 62,836 | D | S |
| 07 Apr, 2026 | James Kihara | Common Stock | D | 1,030 | $22.20 | 27,865 | D | S |
| 05 Apr, 2026 | Mark C. Schneyer | Restricted Stock Units | D | 5,276 | $0.00 | 0 | D | M |
| 05 Apr, 2026 | James Kihara | Restricted Stock Units | D | 2,010 | $0.00 | 0 | D | M |
| 05 Apr, 2026 | James Kihara | Restricted Stock Units | D | 2,010 | $0.00 | 0 | D | M |
| 24 Mar, 2026 | Jennifer J Rhodes | Common Stock | A | 7,515 | $0.00 | 15,124 | D | M |
| 24 Mar, 2026 | Adams Catherine Owen | Common Stock | A | 23,509 | $0.00 | 26,444 | D | M |
| 24 Mar, 2026 | James Kihara | Common Stock | A | 1,627 | - | 26,685 | D | M |
| 24 Mar, 2026 | Elizabeth H.Z. Thompson | Common Stock | A | 6,715 | - | 6,715 | D | M |
| 24 Mar, 2026 | Elizabeth H.Z. Thompson | Common Stock | A | 6,715 | - | 6,715 | D | M |
| 24 Mar, 2026 | Jennifer J Rhodes | Common Stock | A | 7,515 | $0.00 | 15,124 | D | M |
| 24 Mar, 2026 | James Kihara | Common Stock | A | 1,627 | - | 26,685 | D | M |
| 24 Mar, 2026 | James Kihara | Common Stock | A | 1,627 | - | 26,685 | D | M |
| 24 Mar, 2026 | Jennifer J Rhodes | Common Stock | A | 7,515 | $0.00 | 15,124 | D | M |
| 24 Mar, 2026 | Adams Catherine Owen | Common Stock | A | 23,509 | $0.00 | 26,444 | D | M |
| 24 Mar, 2026 | Elizabeth H.Z. Thompson | Common Stock | A | 6,715 | - | 6,715 | D | M |